176 related articles for article (PubMed ID: 9486583)
1. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G
Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Perides G; Charness ME; Tanner LM; Péter O; Satz N; Steere AC; Klempner MS
J Infect Dis; 1998 Feb; 177(2):401-8. PubMed ID: 9466528
[TBL] [Abstract][Full Text] [Related]
3. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of matrix metalloproteinases in bacterial meningitis.
Kieseier BC; Paul R; Koedel U; Seifert T; Clements JM; Gearing AJ; Pfister HW; Hartung HP
Brain; 1999 Aug; 122 ( Pt 8)():1579-87. PubMed ID: 10430840
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
[TBL] [Abstract][Full Text] [Related]
7. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F
Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
10. [Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ].
Nakano A; Tani E; Yamamoto Y; Furuyama J; Miyazaki K
Nihon Rinsho; 1995 Jul; 53(7):1816-21. PubMed ID: 7630025
[TBL] [Abstract][Full Text] [Related]
11. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.
Forsyth PA; Laing TD; Gibson AW; Rewcastle NB; Brasher P; Sutherland G; Johnston RN; Edwards DR
J Neurooncol; 1998 Jan; 36(1):21-9. PubMed ID: 9525822
[TBL] [Abstract][Full Text] [Related]
12. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
14. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
[TBL] [Abstract][Full Text] [Related]
15. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis.
Wong ET; Lee D; Tam A; Gautam S; Wu JK
Clin Lymphoma Myeloma; 2007 Jan; 7(4):305-8. PubMed ID: 17324339
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.
Pagenstecher A; Wussler EM; Opdenakker G; Volk B; Campbell IL
J Neuropathol Exp Neurol; 2001 Jun; 60(6):598-612. PubMed ID: 11398836
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
[TBL] [Abstract][Full Text] [Related]
20. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.
Glass JP; Melamed M; Chernik NL; Posner JB
Neurology; 1979 Oct; 29(10):1369-75. PubMed ID: 573381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]